Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

3T, Cryogen-Free MRI/PET and 3T MRI/SPECT Developed for Research Applications

By BiotechDaily International staff writers
Posted on 26 Sep 2013
Image: The MR Solutions’ range of benchtop, preclinical, 3T cryogen-free MRI scanners provide superior soft tissue contrast and molecular imaging capability, and can be easily accommodated within an existing laboratory (Photo courtesy of MR Solutions).
Image: The MR Solutions’ range of benchtop, preclinical, 3T cryogen-free MRI scanners provide superior soft tissue contrast and molecular imaging capability, and can be easily accommodated within an existing laboratory (Photo courtesy of MR Solutions).
Combined 3T, cryogen-free magnetic resonance imaging/positron emission tomography (MRI/PET) and a 3T MRI/single photon emission computed tomography (SPECT) technology has been developed for multimodality imaging applications for researchers.

MR Solutions (Guilford, Surrey, UK), a developer of preclinical scanning technology, launched the first combined cryogen-free, 3T, MRI/PET and the first 3T, MRI/SPECT scanners at the World Molecular Imaging Conference (WMIC) in Savannah, GA, USA, September 18–21, 2013.

Dr. David Taylor, CEO of MR Solutions, commented, “The combination of high-resolution PET or SPECT with high-performance cryogen-free MRI will provide significant benefits both for academia and pharma. These systems offer researchers for the first time simultaneous multimodality imaging hitherto not commercially available. It is yet another development in our plan to provide the best quality images and functional data in a way that makes it quicker and easier for scientists to work with animals.”

To provide the SPECT images MR Solutions has devised a system where the three gamma camera heads and focusing collimator can be easily clipped on to the front of the bore of the MRI scanner to provide cutting-edge 3D SPECT images. The SPECT images can be registered with the MRI images, providing anatomic-functional combined capability. Moreover, the SPECT gamma camera can be used independently.

The PET capability is provided by new solid-state detectors and ASIC (application-specific integrated circuit) technology, which is integrated in the bore of the MRI scanner. The scanner combines the exquisite structural and functional characterization of tissue provided by MRI with the extreme sensitivity of PET imaging for metabolism and tracking of uniquely labeled cell types or cell receptors. This is especially helpful in cardiology, oncology, and neurology research.

MR Solutions’ range of cryogen-free, benchtop, 3T MRI scanners (16-, 31-, and 72-cm bores), which were only launched at the beginning of 2013, has been a transformative in the field of preclinical scanning. The new technology not only provides excellent soft tissue contrast and high spatial resolution, a vastly reduced stray magnetic field and all the benefits that brings but also allows the magnetic field strength to be easily varied.

Related Links:

MR Solutions



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.